MLV & Co.
1
40M
1
0.08
1
- Areas of investment
Summary
MLV & Co. is the famous Corporate Investor, which was founded in 2009. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the New York.
The high activity for fund was in 2015. The top amount of exits for fund were in 2013. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year.
Among the most popular fund investment industries, there are Health Care, Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular portfolio startups of the fund, we may highlight RedHill Biopharma. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.
The standard case for the fund is to invest in rounds with 4 partakers. Despite the MLV & Co., startups are often financed by Yelin Lapidot Investment House, Shmuel Kabili, OrbiMed. The meaningful sponsors for the fund in investment in the same round are ROTH Capital Partners, Nomura, H. C. Wainwright & Co..
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.08
- Investments by industry
- Drug Discovery (1)
- Pharmaceutical (1)
- Health Care (1)
- Biotechnology (1)
- Investments by region
-
- Israel (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 12
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.